In the tumor microenvironment, IFNγ is secreted by T lymphocytes to reactivate macrophages and CD8+ T cells, but it also stimulates PD-L1 overexpression in tumor cells through the JAKs-STAT1 signaling pathway [16]. Here, IFNG is linked to neoplasm.